10/19/2024 | Press release | Distributed by Public on 10/19/2024 08:18

Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following the Second Dose of Pemivibart in the Phase 3 CANOPY TrialHolmes et al. IDWeek. 2024.

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document